SI-BONE, Inc. - Common Stock (NQ:SIBN)

19.68 -0.23 (-1.16%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SI-BONE, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns ↗

May 02, 2023

U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to...

Via Benzinga

The Latest Analyst Ratings for SI-BONE ↗

May 02, 2023

Via Benzinga

Analysts Remain Bullish On SI-BONE, Forecast Q4's Strength To Continue In 2023 ↗

February 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 28, 2023

Via Benzinga

Monthly Losses In Sight For Major Indexes ↗

February 28, 2023

The Dow Jones Industrial Average is down 81 points this afternoon, looking to deepen its monthly and year-to-date deficits as February comes to a close.

Via Talk Markets

SI-BONE's Earnings Outlook ↗

February 24, 2023

Via Benzinga

Where SI-BONE Stands With Analysts ↗

January 31, 2023

Via Benzinga

Expert Ratings for SI-BONE ↗

January 06, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About SI-BONE ↗

December 20, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About SI-BONE ↗

November 08, 2022

SI-BONE (NASDAQ:SIBN) has observed the following analyst ratings within the last quarter:

Via Benzinga

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

SI-BONE Earnings Preview ↗

April 28, 2023

Via Benzinga

Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 28, 2023

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...

Via Benzinga

Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday ↗

February 28, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

4 Analysts Have This to Say About SI-BONE ↗

November 08, 2022

Within the last quarter, SI-BONE (NASDAQ:SIBN) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for SI-BONE ↗

November 08, 2022

Analysts have provided the following ratings for SI-BONE (NASDAQ:SIBN) within the last quarter:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

Analyst Ratings for SI-BONE ↗

October 11, 2022

SI-BONE (NASDAQ:SIBN) has observed the following analyst ratings within the last quarter:

Via Benzinga

SI-BONE: Q2 Earnings Insights ↗

August 08, 2022

SI-BONE (NASDAQ:SIBN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

5 Analysts Have This to Say About SI-BONE ↗

November 08, 2022

Over the past 3 months, 5 analysts have published their opinion on SI-BONE (NASDAQ:SIBN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗

November 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Fabrinet To Surge 26%? Here Are 5 Other Price Target Changes For Tuesday ↗

November 08, 2022

Needham raised Fabrinet (NYSE: FN) price target from $135 to $140. . Needham analyst Alex Henderson maintained the stock with a Buy rating. Fabrinet shares fell 0.8% to close at $111.39 on Monday.

Via Benzinga

Earnings Preview: SI-BONE ↗

November 04, 2022

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that SI-BONE will report...

Via Benzinga

Earnings Scheduled For November 7, 2022 ↗

November 07, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Earnings Scheduled For August 8, 2022 ↗

August 08, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.